CBX4 and hepatocellular carcinoma: This is consistent with a study conducted in malignant disease who found that Cbx4 expression was elevated in HCC tissues, and Cbx4 overexpression was associated to tumor size, pathologic differentiation, and TNM (tumor, node, metastasis) phases as well as the blood level of alpha-fetoprotein (AFP) [3].